SPECT COINCIDENCE DETECTION EQUIPMENT ADDED TO FDG PET MEDICARE COVERAGE DECISION FOLLOWING ADAC PRESENTATION TO HCFA; INTERIM COVERAGE EFFECTIVE JAN. 1
This article was originally published in The Gray Sheet
Executive Summary
Adac's eleventh-hour presentation of data on coincidence imaging cameras to the Health Care Financing Administration won the company coverage of the technology under the agency's expansion of Medicare reimbursement for positron emission tomography. The revised policy allows coverage of fluorodeoxyglucose PET and coincidence detection imaging for certain lung cancer scanning procedures .